NCT05224830 (Hypercovid) is a clinical trial of Nijmegen questionnaire score in COVID-19, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT05224830?

NCT05224830 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT05224830?

Interventions in NCT05224830: Nijmegen questionnaire score.

What condition does NCT05224830 study?

NCT05224830 studies COVID-19, Hyperventilation Syndrome.

Is NCT05224830 still recruiting?

NCT05224830 is currently completed. Last updated 7 September 2022.

Last reviewed 2022-09-07 · How we verify

NCT05224830: Hypercovid

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relationship Between Hyperventilation Syndrome and SARS-CoV-2 Infection

Completed Last updated 7 September 2022

What this trial tests

trial testing Nijmegen questionnaire score in COVID-19 in 2,846 participants. Completed in 1 July 2022.

Timeline

1 January 2021

Primary endpoint
1 May 2022

1 July 2022

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,846
Start date	1 January 2021
Primary completion	1 May 2022
Estimated completion	1 July 2022
Sites	1 location across France

Drugs / interventions tested

Nijmegen questionnaire score

Conditions studied

COVID-19 — all drugs for COVID-19 →
Hyperventilation Syndrome — all drugs for Hyperventilation Syndrome →

Sponsor

Central Hospital, Nancy, France

Who can join

18 and older, any sex, with COVID-19 or Hyperventilation Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Following an acute COVID-19 infection, many patients suffer from long lasting physical symptoms that may greatly impair quality of life. Persisting dyspnea and other functional respiratory complaints could evoke Hyperventilation Syndrome (HVS) as a putative contributor of the long-COVID presentation in COVID-19 survivors. We aimed to assess the possible relationship between a HVS and previous acute SARS-CoV-2 infection.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Is There a Relationship between Hyperventilation Syndrome and History of Acute SARS-CoV-2 Infection? A Cross-Sectional Study.
Allado E, Poussel M, Hamroun A, Moussu A, et al · · 2022 · cited 4× · PMID 36360494 · DOI 10.3390/healthcare10112154

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05224830 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 7 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05224830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing